Psoriasis Research Today is a free monthly online journal that collates and summarizes the latest research about Psoriasis, including details on treatment, prevention, medication, causes.

Volume 3 (2006), Issue 10 (October)

1. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes.
   J Am Acad Dermatol, 55(4): 637-41. [Abstract] [Full-text]
2. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
   J Am Acad Dermatol, 55(4): 627-31. [Abstract] [Full-text]
3. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis.
   J Am Acad Dermatol, 55(4): 607-13. [Abstract] [Full-text]
4. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study.
   J Am Acad Dermatol, 55(4): 598-606. [Abstract] [Full-text]
5. Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients.
   J Am Acad Dermatol, 55(4): 590-7. [Abstract] [Full-text]
6. Extrasynovial ultrasound abnormalities in the psoriatic finger. Prospective comparative power-doppler study versus rheumatoid arthritis.
   Joint Bone Spine, 73(5): 527-31. [Abstract] [Full-text]
7. TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology.
   Joint Bone Spine, 73(5): 547-53. [Abstract] [Full-text]
8. Risk of myocardial infarction in patients with psoriasis.
   JAMA, 296(14): 1735-41. [Abstract] [Full-text]
9. Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease.
   Expert Opin Investig Drugs, 15(11): 1453-68. [Abstract] [Full-text]
10. Prevalence of cardiovascular risk factors in patients with psoriasis.
    J Am Acad Dermatol, 55(5): 829-35. [Abstract] [Full-text]
11. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
    J Am Acad Dermatol, 55(5): 814-22. [Abstract] [Full-text]

© 2004-2008 Psoriasis Research Today. All Rights Reserved.